STAT
JUNE 29, 2023
In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years of incarceration. He was prescribed a drug cocktail, a combination of interferon and ribavirin, that proved ineffective and gave him severe side effects. A nurse told him he had only six months to live. recalled.
STAT
DECEMBER 13, 2024
billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Integra X Files
JUNE 19, 2023
The cards provided a credit of $600 for eligible prescription drugs with a co-insurance of 5% to 10% depending on income. Seniors with incomes up to 135% of the poverty level were eligible for an additional $600 credit in 2005. They have an incentive to keep prices as low as possible.
European Pharmaceutical Review
OCTOBER 19, 2022
1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Patents are often described as the ‘lifeblood’ of pharmaceutical companies.
pharmaphorum
FEBRUARY 23, 2022
The case concerns actions allegedly taken by Servier between 2005 and 2007, in which the pharma company entered into “pay for delay” agreements with four generic drugmakers to stall competition for its blockbuster anti-hypertension drug perindopril (brand name Coversyl).
Pharma in Brief
JANUARY 10, 2024
Expected highlights for 2024 include a final PTA regime, more details on PMPRB drug pricing guidelines and national pharmacare, and fall-out from the US mass drug importation program targeting Canadian medicines. The Guidance was last updated in 2005.
Expert insights. Personalized for you.
246 
Let's personalize your content